OR WAIT null SECS
© 2021 MJH Life Sciences and Spectroscopy Online. All rights reserved.
© 2021 MJH Life Sciences™ and Spectroscopy Online. All rights reserved.
October 18, 2021
These applications will help you find the right solution for your analytical needs. Agilent solutions build confidence and reliability in all your analytical measurements.
Partner with Agilent, benefit from industry-leading nucleic acid experience to advance lead oligo candidates from clinic to market with a goal of patient health and safety.
In living cells, the process of reversible hybridization is a critical requirement to the process of replication, transcription and translation.
The appetite for higher throughput analytical methods has increased in the past years alongside the acceleration of oligo production and use.
Synthetic DNA- and RNA-based oligonucleotides are among many successful biotherapeutic drugs to treat many different kinds of illnesses.
Oligonucleotides synthesized using phosphoramidite chemistry are analyzed and purified using ion-pair reversed-phase liquid chromatography and anion-exchange chromatography.
The purification of oligonucleotides (ONs) can be particularly challenging because of the high similarity of target and impurities.
The urgency caused by the SARS-CoV-2 pandemic of 2020 prompted policy makers and pharmaceutical firms alike to develop and deploy mRNA vaccines with unprecedented speed.
October 20, 2020